The Asia Pacific Biosurgery Market is expected to witness market growth of 8.3% CAGR during the forecast period (2019-2025).
Biosurgery has also been labeled as maggot therapy or larva therapy. These maggots or larvae can heal chronically-infected wounds that resist antibiotics. A biosurgery procedure with maggot debridement therapy has proven to be effective for diabetic patients. The increased prevalence of diabetes and spinal injuries is expected to sustain the demand for biosurgery in the years to come. Additionally, biosurgery is also useful for neurological, orthopedic, and gynecology surgeries. This can substantially boost the product demand.
Increased demand for minimally invasive surgery alongside the continual rise in the geriatric population suffering from chronic conditions is projected to expand the biosurgery market. Biosurgery products can reduce the risks that might occur due to tissue contamination. This can significantly drive demand. Moreover, effective measures for blood loss during surgeries are likely to boost the adoption of these procedures over the forecast period.
The Asia Pacific (APAC) region is expected to emerge as a major region for biosurgery with the highest growth rate over the forecast period. Japan was one of the dominant countries in this region during 2018 because of its huge geriatric population and swift economic growth. Moreover, an increase in the awareness about the advanced surgical procedures is projected to boost the market growth during the forecast period.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
By Product
By Country
Companies Profiled
Unique Offerings from the Publisher
Biosurgery has also been labeled as maggot therapy or larva therapy. These maggots or larvae can heal chronically-infected wounds that resist antibiotics. A biosurgery procedure with maggot debridement therapy has proven to be effective for diabetic patients. The increased prevalence of diabetes and spinal injuries is expected to sustain the demand for biosurgery in the years to come. Additionally, biosurgery is also useful for neurological, orthopedic, and gynecology surgeries. This can substantially boost the product demand.
Increased demand for minimally invasive surgery alongside the continual rise in the geriatric population suffering from chronic conditions is projected to expand the biosurgery market. Biosurgery products can reduce the risks that might occur due to tissue contamination. This can significantly drive demand. Moreover, effective measures for blood loss during surgeries are likely to boost the adoption of these procedures over the forecast period.
The Asia Pacific (APAC) region is expected to emerge as a major region for biosurgery with the highest growth rate over the forecast period. Japan was one of the dominant countries in this region during 2018 because of its huge geriatric population and swift economic growth. Moreover, an increase in the awareness about the advanced surgical procedures is projected to boost the market growth during the forecast period.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
By Product
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Biosurgery Market by Application
Chapter 5. Asia Pacific Biosurgery Market by Product
Chapter 6. Asia Pacific Biosurgery Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
Methodology
LOADING...
